| Smiles |
O=C(C=C(C)C)CC(C9(C1(C(=C2(OC(=CC1)C3(CCC(C(C3(CC2))(C)C)OC5(OCC(OC4(OC(C(O)C(C4NC(=O)C)O)CO))C(C5OC6(OC(C(O)C(C6NC(=O)C)O)COC7(OC(C(O)C(C7OC8(OC(C(O)C(C8O)O)CO))O)CO)))O))(C)))CC9)(C)))C
|
| CAS number |
865369-24-0
|
| Polar Surface Area |
439,79
|
| calculated LogS |
-5,39
|
| Molweight |
1303,45
|
| calculated LogP |
-1,9785
|
| H-Acceptors |
29
|
| H-Donors |
15
|
| Ro5 violations |
3
|
| Druglikeness |
-11,827
|
| DrugScore |
0,1052374
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
high
|
| Fish Toxicity |
High FHMT
|
| Fish Toxicity2 |
1,0807
|
| Rat Acute Toxicity |
2,7835
|
| Acute Oral Toxicity |
III
|
| Caco-2 Permeability |
Caco2-
|
| Caco-2 Permeability2 |
-0,1628
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor |
Inhibitor
|
| P-glycoprotein Inhibitor2 |
Non-inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition2 |
Non-inhibitor
|
| CYP450 2C9 Substrate |
Non-substrate
|
| Tetrahymena Pyriformis Toxicity |
High TPT
|
| Tetrahymena Pyriformis Toxicity2 |
0,5914
|
| AMES Toxicity |
Non AMES toxic
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Substrate |
Non-substrate
|
| Biodegradation |
Not ready biodegradable
|
| Carcinogens |
Non-carcinogens
|
| Blood-Brain Barrier |
BBB-
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Honey Bee Toxicity |
High HBT
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Carcinogenicity (Three-class) |
Non-required
|
| Human Intestinal Absorption |
HIA-
|
| Structure |
865369-24-0
|
